Cite
HARVARD Citation
Marmé, F. et al. (2016). Utility of the CPS + EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy. European journal of cancer. pp. 65-74. [Online].